About: Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2000 (uk) im Februar 2000 veröffentlichter wissenschaftlicher Artikel (de) wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch (gsw) article scientifique publié en 2000 (fr)
publication date	wds:Q58819293-73A7412C-A39F-448C-B27D-6B823E5A9311
publication date	2000-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58819293-227981F5-E9F4-4496-B583-5834EAE27A77
language of work or name	English
author name string	wds:Q58819293-05C830CE-E0BF-4E56-A98E-7C364E03457E wds:Q58819293-10766B1F-1E7A-420D-9E5E-2C1551D2BF4F wds:Q58819293-3CCDB208-A4FC-4232-A4B4-173ABF6B0186 wds:Q58819293-52FF7644-CBAB-4DBB-81E0-502B98C27137 wds:Q58819293-5D48D812-7B29-461D-96A7-FDEB7F7D4D97 wds:Q58819293-87E8F0D3-8C2D-401F-8431-2B530849D567 wds:Q58819293-89A2B391-3EFD-4EB7-ACF7-588A0EEB70EE wds:Q58819293-98E60E79-C7F6-40D4-AB8A-0CB9FD584C86 wds:Q58819293-9F34DE13-30CC-4C71-841D-7E50BE9E7DF5 wds:Q58819293-CA1EDBD2-4995-442B-BF21-3CF7EC50B6FB
author name string	Epstein AE Estes NA 3rd Rea RF Shen WK Spirito P Maron BJ Link MS Almquist AK Daubert JP Favale S
rdfs:label	Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy (en) Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy (nl)
skos:prefLabel	Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy (en) Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy (nl)
name	Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy (en) Efficacy of Implantable Cardioverter–Defibrillators for the Prevention of Sudden Death in Patients with Hypertrophic Cardiomyopathy (nl)
author	wds:Q58819293-6FDBF88B-B964-4BBF-8894-C352F74F30DB wds:Q58819293-D21BE342-B418-4532-A3C5-5F70EE533B86
author	Giuseppe Boriani Gust Bardy
title	wds:Q58819293-A514BBF3-B335-47EC-8521-5956D9FAA1B2
title	Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy (en)
page(s)	wds:Q58819293-90895DB9-1776-43B9-840A-5BB66B3B08B5
page(s)	365-373
instance of	wds:Q58819293-60319EDE-0AFC-4674-9B75-92894DE3B995
instance of	scholarly article
main subject	wds:Q58819293-0CDD9DEE-735F-419C-9F1D-44BEB18C0EFE wds:Q58819293-6204A7F9-6123-4F73-A0AE-E0F019CF3430 wds:Q58819293-7242637A-C514-4E09-8C45-7799E37170A8
main subject	defibrillator Patients hypertrophic cardiomyopathy
PubMed ID	wds:Q58819293-73941D2B-37CE-44B4-85E6-093D049B14FD
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10666426
PubMed ID	10666426
published in	wds:Q58819293-8BB110D4-8728-498D-8C2D-AC2EEBF5370C
published in	The New England Journal of Medicine
issue	wds:Q58819293-6438C08C-8540-4570-8187-C47D120076EC
volume	wds:Q58819293-3F691904-639B-4EAA-9A4D-883B415D6DE3
issue	6
volume	342
DOI	wds:Q58819293-232FAC04-C694-4784-B266-6F7BB0B22BC4
DOI	http://dx.doi.org/10.1056/NEJM200002103420601
DOI	10.1056/NEJM200002103420601
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58819293
is cites work of	Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration Implantable cardioverter defibrillator in high-risk long QT syndrome patients American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the Euro Brugada syndrome Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia Athletes with Implantable Cardioverter Defibrillators Management of hypertrophic cardiomyopathy in children Cardiac pacing: how it started, where we are, where we are going Implantable cardiac arrhythmia devices--Part II: implantable cardioverter defibrillators and implantable loop recorders. Current status of implantable cardioverter-defibrillator therapy in heart failure A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Pacing-induced electrophysiological remodeling in hypertrophic obstructive cardiomyopathy--observations on cardiac memory. Sudden Death in Noncoronary Heart Disease Is Associated With Delayed Paced Ventricular Activation Experimental therapies in hypertrophic cardiomyopathy Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy Hypertrophic cardiomyopathy Genetic basis of hypertrophic cardiomyopathy. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study Hypertrophic cardiomyopathy The implantable cardioverter defibrillator Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience A primer on arrhythmias in patients with hypertrophic cardiomyopathy Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software